about
Human alpha-L-iduronidase: cDNA isolation and expressionReplacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I.Decreased performance in IDUA knockout mouse mimic limitations of joint function and locomotion in patients with Hurler syndromeComparison of Endovascular and Intraventricular Gene Therapy With Adeno-Associated Virus-α-L-Iduronidase for Hurler DiseaseBone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system.Long-term effects of bone marrow transplantation in dogs with mucopolysaccharidosis I.Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy.Enzyme replacement therapy for the mucopolysaccharide storage disorders.Effects of neonatal enzyme replacement therapy and simvastatin treatment on cervical spine disease in mucopolysaccharidosis I dogs.Arterial pathology in canine mucopolysaccharidosis-I and response to therapyGlycosaminoglycan storage disorders: a reviewSuccessful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis IMorphologic and biochemical studies of canine mucopolysaccharidosis I.A review of gene therapy in canine and feline models of lysosomal storage disorders.Enzyme replacement in a canine model of Hurler syndrome.Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.Dried blood spots for the enzymatic diagnosis of lysosomal storage diseases in dogs and cats.Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation.Renal failure associated with mucopolysaccharidosis type I in a cat from a MPS I research colony.
P2860
Q28609270-481D0456-CDA9-4DF5-A0F5-D4205E5F20F3Q30499512-76C4DDBD-74A7-4B49-892E-8A3A5154D979Q30665510-86D67E2F-35B8-4FAA-BF4B-CDEC674AA566Q33974900-C810E235-65FD-4FD5-8E12-C7BE3B57B854Q34165972-E5A5BFF4-294A-4B86-8E8F-B6B5E24705C5Q34425239-ABF7DF40-6C85-47BF-8E7E-374AEDEBB517Q34583538-92014D7A-988A-42BC-B58B-912FC2D7004BQ34628680-658F1C94-83FB-4D92-B915-8082C8A535DAQ34633305-76758A32-9B7F-4FEA-9933-CCC7D5D21712Q34883690-18E74171-7080-41B4-AEC2-DEB5C227F211Q35367599-D1CAF9E2-4026-4D17-8524-CDDB4136674DQ35554420-D8A05951-9EC9-45E2-A4A0-39BBF501015DQ35858094-D02EAA3D-7F27-43BE-9F0F-B14118B972C2Q35894676-C645F0B1-547B-45F8-ACA9-3F84F159627AQ36013555-EADFBAC1-25A4-493C-876C-4B9BEBE4E405Q36429491-81AD8931-6287-453E-9559-844AC115E33CQ36472618-124C6DBB-07AA-4E6F-B86B-C7AD0C0BF008Q37480537-B9B58D27-3345-42D4-9784-B5D1AE053D16Q38700766-F13B8032-E54E-4D14-A267-C8B3465DC961
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1983
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A canine model of human alpha-L-iduronidase deficiency.
@en
A canine model of human alpha-L-iduronidase deficiency.
@nl
type
label
A canine model of human alpha-L-iduronidase deficiency.
@en
A canine model of human alpha-L-iduronidase deficiency.
@nl
prefLabel
A canine model of human alpha-L-iduronidase deficiency.
@en
A canine model of human alpha-L-iduronidase deficiency.
@nl
P2093
P2860
P356
P1476
A canine model of human alpha-L-iduronidase deficiency.
@en
P2093
Constantopoulos G
Neufeld EF
Spellacy E
P2860
P304
P356
10.1073/PNAS.80.19.6091
P407
P577
1983-10-01T00:00:00Z